Funds And Strategies
  • Business
  • Stocks
  • World News
  • Investing
  • Business
  • Stocks
  • World News
  • Investing

Funds And Strategies

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025
June 4, 2025
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

previous post
5 Biggest Blockchain ETFs in 2025
next post
Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 Vaccines

Related Posts

Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical...

May 13, 2025

Excellent Gold Intersections Verified at Kiimala Project

May 12, 2025

James Henry Anderson: US$3,600 Gold, US$40+ Silver —...

September 9, 2025

Precious Metals & Critical Minerals Hybrid Investor Conference...

May 17, 2025

Newmont to Delist from Toronto Stock Exchange as...

September 15, 2025

Editor’s Picks: Gold Pulls Back, Experts Not Worried;...

May 4, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (235)
    • Investing (1,174)
    • Stocks (206)
    • World News (648)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 fundsandstrategies.com | All Rights Reserved